Richard Bulbulia
- Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management 9
-
- Cardiovascular Health and Disease Prevention 38
-
- Cerebrovascular and Carotid Artery Diseases 49
- Neurology top 5%
- Intracranial Aneurysms: Treatment and Complications 19
- Rehabilitation top 5%
-
- Acute Ischemic Stroke Management 19
-
- Diagnosis and Treatment of Venous Diseases 10
-
- Health and Medical Research Impacts 6
-
- Health Systems, Economic Evaluations, Quality of Life 6
- Co-authors
- Alison HallidayGert J. de BorstLouise BowmanK R PoskittHans‐Henning EcksteinLeo H. BonatiPeter A. RinglebRebecca Llewellyn-Bennett
- Partner nations
- United KingdomNetherlandsUnited States
In The Last Decade
Richard Bulbulia
84 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Internal Medicine 289
- Cardiology and Cardiovascular Medicine 728
- Pulmonary and Respiratory Medicine 857
- Neurology 308
- Rehabilitation 102
Countries citing papers authored by Richard Bulbulia
This map shows the geographic impact of Richard Bulbulia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Bulbulia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Bulbulia more than expected).
Fields of papers citing papers by Richard Bulbulia
This network shows the impact of papers produced by Richard Bulbulia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Bulbulia. The network helps show where Richard Bulbulia may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Richard Bulbulia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 1 | |
| 6 | 2021 | 11 | |
| 7 | 2020 | 26 | |
| 8 | 2020 | 3 | |
| 9 | 2020 | 18 | |
| 10 | 2020 | 1 | |
| 11 | 2019 | 14 | |
| 12 | 2019 | 2 | |
| 13 | 2019 | 0 | |
| 14 | 2019 | 1 | |
| 15 | 2019 | 1 | |
| 16 | 2018 | 28 | |
| 17 | 2018 | 2 | |
| 18 | 2015 | 30 | |
| 19 | MRC/BHF heart protection study (HPS): Mortality, cancer incidence and major vascular events during 4 years post-trial follow-up of HPS | 2007 | 2 |
| 20 | 2002 | 34 |
About Richard Bulbulia
Richard Bulbulia is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine, having authored 88 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cerebrovascular and Carotid Artery Diseases (49 papers), Cardiovascular Health and Disease Prevention (38 papers), Intracranial Aneurysms: Treatment and Complications (19 papers), Acute Ischemic Stroke Management (19 papers), Diagnosis and Treatment of Venous Diseases (10 papers), Venous Thromboembolism Diagnosis and Management (9 papers), Health and Medical Research Impacts (6 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). The work is most often cited by research in Internal Medicine (289 citations), Cardiology and Cardiovascular Medicine (728 citations) and Pulmonary and Respiratory Medicine (857 citations). Richard Bulbulia has collaborated with scholars based in United Kingdom, Netherlands and United States. Frequent co-authors include Alison Halliday, Gert J. de Borst, Louise Bowman, K R Poskitt, Hans‐Henning Eckstein, Leo H. Bonati, Peter A. Ringleb, Rebecca Llewellyn-Bennett, Manjit Gohel and Martin M. Brown. Their work appears in journals such as New England Journal of Medicine, The Lancet and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.